Case reports Chronic diarrhoea (five to 10 watery stools), was seen in three women, aged 67 to 80 years, after two to eight weeks of treatment with Cyclo 3 Fort, one tablet thrice daily. Cyclo 3 Fort was given to these three women as a symptomatic treatment for mild ankle swelling and venous discomfort -that is, a feeling of a 'heavy leg' or painful varicosities. None of these patients had a history of chronic arthritis, thyroid disease or other autoimmune disease. Total colonoscopy was performed after four to seven weeks of diarrhoea. Endoscopical examination of colonic mucosa was normal in all three cases. Three biopsy samples were taken from each patient from the caecum, splenic flexure, and sigmoid. Histological examination of the colonic biopsy specimens showed in all three cases a mild lamina propria infiltration by mononuclear cells. The intraepithelial lymphocyte count was increased in all patients and in all sites, ranging from 44 to 100% in the caecum, and from 36 to 40% in the sigmoid (Table) . The collagen subepithelial layer thickness was within the normal range, from 0 to 7 ,u, except in the caecum of patient 2 (11 u). Immunopathological examination of the sigmoid biopsy specimens in patients 1 Diarrhoea recurred during the rechallenge period. The histological examination of the sigmoid mucosa was normal both before and after rechallenge. The intraepithelial lymphocyte count was normal, below 5%, and there was no evidence of an increased number of mononuclear cells in the lamina propria, either before or after rechallenge. The immunopathological picture, however, of the sigmoid mucosa was different, before and after the rechallenge. Before the rechallenge, CD25 + lamina propria mononuclear cells were not seen. HLA-DR was normally expressed by some lamina propria mononuclear cells but not expressed by the colonic epithelial cells (Fig IA) . After rechallenge, CD25 expression was seen in some lamina propria mononuclear cells, mainly macrophages. There were no CD25 + intraepithelial lymphocytes. HLA-DR antigen expression was seen on epithelial cells, both in the crypts and the intercryptal spaces (Fig iB) . Further studies are needed to determine the component of the drug that participates in the intestinal adverse reaction and the site and the mechanism of the colonic immune cell activation.
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